All Cosmos Bio-Tech Holding (TPE:4148) Risk Assessment

View and export this data going back to 2017. Start your Free Trial

What is All Cosmos Bio-Tech Holding Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of All Cosmos Bio-Tech Holding is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of All Cosmos Bio-Tech Holding's Risk Assessment

For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

All Cosmos Bio-Tech Holding's Risk Assessment Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's Risk Assessment distribution charts can be found below:

* The bar in red indicates where All Cosmos Bio-Tech Holding's Risk Assessment falls into.

All Cosmos Bio-Tech Holding (TPE:4148) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

All Cosmos Bio-Tech Holding Risk Assessment Related Terms

Thank you for viewing the detailed overview of All Cosmos Bio-Tech Holding's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

All Cosmos Bio-Tech Holding (TPE:4148) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » All Cosmos Bio-Tech Holding Corp (TPE:4148) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

PLO 650, Jalan Keluli 7, Pasir Gudang Industrial Estate, Johor Bahru, JHR, MYS, 81700

Website

https://www.allcosmos.com

All Cosmos Bio-Tech Holding Corp focuses on the production and marketing of biochemical and bio-organic fertilizers and agriculture-related activities. The company produces 30 different types of fertilizers for the vibrant Malaysian market as well as for the larger Asia Pacific Region. The products are also exported to Taiwan, Indonesia, Vietnam, China, Cambodia and Philippines. Its segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. It generates revenue from Malaysia.

All Cosmos Bio-Tech Holding (TPE:4148) Headlines

No Headlines